Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $2.2 million.

  • National Research's Cash & Equivalents fell 3588.56% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3588.56%. This contributed to the annual value of $4.2 million for FY2024, which is 3637.46% down from last year.
  • According to the latest figures from Q3 2025, National Research's Cash & Equivalents is $2.2 million, which was down 3588.56% from $5.3 million recorded in Q2 2025.
  • In the past 5 years, National Research's Cash & Equivalents registered a high of $54.4 million during Q4 2021, and its lowest value of $485000.0 during Q2 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $22.5 million (2023), whereas its average is $21.6 million.
  • In the last 5 years, National Research's Cash & Equivalents tumbled by 9784.41% in 2024 and then soared by 98742.27% in 2025.
  • National Research's Cash & Equivalents (Quarter) stood at $54.4 million in 2021, then tumbled by 53.96% to $25.0 million in 2022, then crashed by 73.42% to $6.7 million in 2023, then tumbled by 36.37% to $4.2 million in 2024, then plummeted by 47.58% to $2.2 million in 2025.
  • Its Cash & Equivalents stands at $2.2 million for Q3 2025, versus $5.3 million for Q2 2025 and $2.5 million for Q1 2025.